S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government's initial estimate
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dubai's sky-high aspirations find a new outlet as it hosts a jet suit race for 'Iron Man' pilots
Apple Cancels Its 10-Year Electric Car Project, Moves Some Employees to AI Division
The Strategic Gold Play You Haven't Heard About (Ad)
Leaders, Here Are 4 Ways You're Inadvertently Destroying Trust in the Workplace (and What to Do Instead)
Wendy's says it has no plans to raise prices during the busiest times at its restaurants
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government's initial estimate
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dubai's sky-high aspirations find a new outlet as it hosts a jet suit race for 'Iron Man' pilots
Apple Cancels Its 10-Year Electric Car Project, Moves Some Employees to AI Division
The Strategic Gold Play You Haven't Heard About (Ad)
Leaders, Here Are 4 Ways You're Inadvertently Destroying Trust in the Workplace (and What to Do Instead)
Wendy's says it has no plans to raise prices during the busiest times at its restaurants
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government's initial estimate
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dubai's sky-high aspirations find a new outlet as it hosts a jet suit race for 'Iron Man' pilots
Apple Cancels Its 10-Year Electric Car Project, Moves Some Employees to AI Division
The Strategic Gold Play You Haven't Heard About (Ad)
Leaders, Here Are 4 Ways You're Inadvertently Destroying Trust in the Workplace (and What to Do Instead)
Wendy's says it has no plans to raise prices during the busiest times at its restaurants
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government's initial estimate
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Dubai's sky-high aspirations find a new outlet as it hosts a jet suit race for 'Iron Man' pilots
Apple Cancels Its 10-Year Electric Car Project, Moves Some Employees to AI Division
The Strategic Gold Play You Haven't Heard About (Ad)
Leaders, Here Are 4 Ways You're Inadvertently Destroying Trust in the Workplace (and What to Do Instead)
Wendy's says it has no plans to raise prices during the busiest times at its restaurants

Talaris Therapeutics (TALS) News Today

Notice: This company has been marked as potentially delisted and may not be actively trading.
SourceHeadline
benzinga.com logoLongitude Venture Partners III, L.P.'s Net Worth
benzinga.com - February 25 at 9:31 PM
marketbeat.com logoRA Capital Management L.P. Takes Position in Talaris Therapeutics, Inc. (NASDAQ:TALS)
marketbeat.com - December 12 at 9:44 AM
msn.com logoTalaris Therapeutics (TALS) Price Target Increased by 562.50% to 135.15
msn.com - November 1 at 8:40 AM
msn.com logoTalaris Therapeutics goes ex-dividend tomorrow
msn.com - October 19 at 3:47 PM
finanznachrichten.de logoTalaris Therapeutics, Inc.: Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio
finanznachrichten.de - October 18 at 8:02 AM
msn.com logoTalaris shareholders approve merger, 1-for-10 reverse stock split
msn.com - October 17 at 10:28 PM
finance.yahoo.com logoTalaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline Bio
finance.yahoo.com - October 17 at 10:28 PM
marketwatch.com logoShares of Talaris Therapeutics Climb 5.2% on Special Dividend Tied to Merger
marketwatch.com - October 6 at 8:19 PM
finance.yahoo.com logoTalaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline Bio
finance.yahoo.com - October 6 at 8:19 PM
finance.yahoo.com logoNew York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris Therapeutics
finance.yahoo.com - October 4 at 9:59 AM
finance.yahoo.com logoWe're Keeping An Eye On Talaris Therapeutics' (NASDAQ:TALS) Cash Burn Rate
finance.yahoo.com - September 12 at 5:34 PM
marketbeat.com logoAcadian Asset Management LLC Raises Holdings in Talaris Therapeutics, Inc. (NASDAQ:TALS)
marketbeat.com - September 7 at 5:23 AM
markets.businessinsider.com logoSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, DEN, TALS, QUOT
markets.businessinsider.com - August 15 at 6:25 PM
finance.yahoo.com logoImmunoFree Inc. has Acquired Talaris Therapeutics, Inc.'s Tolerance Business
finance.yahoo.com - August 14 at 3:38 PM
markets.businessinsider.com logoSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NEX, TALS, QUOT, SURF
markets.businessinsider.com - August 8 at 8:33 AM
benzinga.com logoMoore Kuehn Encourages RETA, TALS, INPX, and DEN Investors to Contact Law Firm
benzinga.com - July 28 at 4:44 PM
markets.businessinsider.com logoSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Talaris Therapeutics, Inc. (TALS)
markets.businessinsider.com - July 27 at 11:10 AM
markets.businessinsider.com logoSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NETI, QUOT, TALS, CFMS
markets.businessinsider.com - July 18 at 1:26 PM
msn.com logoTalaris Therapeutics: Cashing Out Ahead Of Tourmaline Merger
msn.com - July 18 at 8:26 AM
marketbeat.com logoShort Interest in Talaris Therapeutics, Inc. (NASDAQ:TALS) Decreases By 71.7%
marketbeat.com - July 14 at 5:24 PM
msn.com logoTalaris Therapeutics (TALS) Price Target Increased by 66.67% to 12.75
msn.com - July 6 at 8:45 PM
markets.businessinsider.com logoIMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, DICE, NEX, NETI
markets.businessinsider.com - June 27 at 7:57 AM
businesswire.com logoTALARIS THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Talaris Therapeutics, Inc. - TALS
businesswire.com - June 26 at 11:07 PM
benzinga.com logoSHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Talaris Therapeutics, Inc. Merger
benzinga.com - June 23 at 7:17 PM
bizjournals.com logoTalaris Therapeutics announces merger after layoffs
bizjournals.com - June 23 at 9:16 AM
bizjournals.com logoNY biotech to go public by merging with Boston firm that laid off 95% of staff
bizjournals.com - June 22 at 11:54 PM
msn.com logoTalaris jumps 29% on merger with Tourmaline Bio in all-stock deal
msn.com - June 22 at 6:54 PM
markets.businessinsider.com logoIMPORTANT ALERT: Halper Sadeh LLC Investigates TALS, SURF, NEX, CIR
markets.businessinsider.com - June 22 at 6:54 PM
finanznachrichten.de logoTalaris Therapeutics, Inc.: Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
finanznachrichten.de - June 22 at 1:54 PM
msn.com logoTalaris Soars on All Stock Deal with Tourmaline Bio
msn.com - June 22 at 1:54 PM
stockhouse.com logoTALS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Talaris Therapeutics, Inc. Is Fair to Shareholders
stockhouse.com - June 22 at 1:54 PM
benzinga.com logoWhy Talaris Therapeutics Stock Is Shooting Higher Today
benzinga.com - June 22 at 1:54 PM
seekingalpha.com logoTalaris to merge with Tourmaline Bio in all-stock deal
seekingalpha.com - June 22 at 8:53 AM
markets.businessinsider.com logoTourmaline, Talaris Announce All-stock Merger
markets.businessinsider.com - June 22 at 8:53 AM
finance.yahoo.com logoTalaris Therapeutics and Tourmaline Bio Announce Merger Agreement
finance.yahoo.com - June 22 at 8:53 AM
marketbeat.com logo
marketbeat.com - June 22 at 7:26 AM
benzinga.com logoTalaris Therapeutics Board Member Awarded $50K Worth of Stock Options
benzinga.com - June 15 at 3:41 PM
benzinga.com logoTalaris Therapeutics Director Awarded $50K Worth of Stock Options
benzinga.com - June 15 at 3:41 PM
marketbeat.com logoTalaris Therapeutics, Inc. (NASDAQ:TALS) Director Sells $62,530.74 in Stock
marketbeat.com - June 9 at 7:49 PM
finanznachrichten.de logoTalaris Therapeutics, Inc.: Talaris Therapeutics Announces Leadership Transition
finanznachrichten.de - May 26 at 11:51 AM
markets.businessinsider.com logoTalaris Therapeutics Names Mary Kay Fenton Interim CEO & President - Quick Facts
markets.businessinsider.com - May 26 at 11:51 AM
msn.com logoTalaris Therapeutics appoints current CFO Mary Kay as interim CEO
msn.com - May 26 at 11:51 AM
finance.yahoo.com logoTalaris Therapeutics Announces Leadership Transition
finance.yahoo.com - May 26 at 11:51 AM
finance.yahoo.com logoTalaris Therapeutics, Inc. (NASDAQ:TALS) most popular amongst private equity firms who own 34% of the shares, institutions hold 30%
finance.yahoo.com - May 20 at 8:44 AM
marketbeat.com logoQ2 2023 EPS Estimates for Talaris Therapeutics, Inc. (NASDAQ:TALS) Increased by SVB Leerink
marketbeat.com - May 19 at 7:33 AM
bizjournals.com logoWellesley biotech announces 2nd round of layoffs this year, closure of Kentucky facilities
bizjournals.com - May 3 at 10:24 AM
bizjournals.com logoTalaris Therapeutics closing Louisville facilities, laying off 51
bizjournals.com - May 2 at 7:23 PM
benzinga.com logoTalaris Therapeutics Stock (NASDAQ:TALS), Dividends
benzinga.com - April 18 at 3:13 PM
markets.businessinsider.com logoSVB Securities Reaffirms Their Hold Rating on Talaris Therapeutics (TALS)
markets.businessinsider.com - April 5 at 9:56 AM
seekingalpha.com logoTALS Talaris Therapeutics, Inc.
seekingalpha.com - March 21 at 8:09 AM
Get Talaris Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TALS and its competitors with MarketBeat's FREE daily newsletter.



TALS Media Mentions By Week

TALS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TALS
News Sentiment

0.00

0.67

Average
Medical
News Sentiment

TALS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TALS Articles
This Week

1

1

TALS Articles
Average Week

Get Talaris Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TALS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TALS) was last updated on 2/29/2024 by MarketBeat.com Staff